[HTML][HTML] Salivary gland carcinoma: novel targets to overcome treatment resistance in advanced disease

L Di Villeneuve, IL Souza, FDS Tolentino… - Frontiers in …, 2020 - frontiersin.org
Salivary gland carcinomas (SGC) account for less than 5% of head and neck malignant
neoplasms, further subcategorized in over 20 histological subtypes. For the most part …

TRK fusion cancers in children: a clinical review and recommendations for screening

CM Albert, JL Davis, N Federman… - Journal of Clinical …, 2019 - ascopubs.org
Chromosomal translocations involving the NTRK1, NTRK2, and NTRK3 genes (TRK
fusions), which encode the neurotrophin tyrosine kinase receptors TRKA, TRKB, and TRKC …

[HTML][HTML] Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study

TM Stevens, AO Kovalovsky, C Velosa, Q Shi, Q Dai… - Modern …, 2015 - nature.com
Mammary analog secretory carcinoma (MASC) is a recently recognized low-grade salivary
carcinoma characterized by a specific ETV6 rearrangement. We describe 14 new MASCs …

Mammary Analogue Secretory Carcinoma of Salivary Glands: A Clinicopathologic and Molecular Study Including 2 Cases Harboring: ETV6-X: Fusion

Y Ito, K Ishibashi, A Masaki, K Fujii… - The American Journal …, 2015 - journals.lww.com
Mammary analogue secretory carcinoma (MASC) is a recently described low-grade
carcinoma with morphologic and genetic similarity, including ETV6-NTRK3 fusion, to …

Systematic review of mammary analog secretory carcinoma of salivary glands at 7 years after description

BA Khalele - Head & neck, 2017 - Wiley Online Library
Background Mammary analog secretory carcinoma of the salivary glands (MASCSG) is a
newly introduced malignant tumor of the salivary glands. For decades, it has been confused …

Secretory carcinoma of the skin harboring ETV6 gene fusions: a cutaneous analogue to secretory carcinomas of the breast and salivary glands

JA Bishop, JM Taube, A Su, SW Binder… - The American Journal …, 2017 - journals.lww.com
Mammary analogue secretory carcinoma is a low-grade salivary gland carcinoma that
exhibits analogous features to secretory carcinoma of the breast including the presence of at …

Newly described entities in salivary gland pathology

A Skálová, DR Gnepp, JS Lewis Jr… - The American journal …, 2017 - journals.lww.com
Salivary glands may give rise to a wide spectrum of different tumors. This review
concentrates on 4 salivary gland tumors that have been accepted in the recent literature as …

A systematic review of secretory carcinoma of the salivary gland: where are we?

LDB Alves, AC de Melo, TA Farinha… - Oral Surgery, Oral …, 2021 - Elsevier
Objective The aim of this systematic review was to describe the epidemiology, diagnostic
criteria, differential diagnosis, treatment, prognostic factors, and treatment outcomes of …

Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin

F Baghai, F Yazdani, A Etebarian, A Garajei… - … -Research and Practice, 2017 - Elsevier
Background Mammary analogue secretory carcinoma (MASC) is a newly recognized
salivary gland tumor that harbors a characteristic balanced chromosomal translocation t (12; …

Mammary analogue secretory carcinoma

TM Stevens, V Parekh - Archives of pathology & laboratory …, 2016 - meridian.allenpress.com
Mammary analogue secretory carcinoma (MASC) is a recently described salivary gland
tumor that shares the same histologic appearance and ETV6 gene (12p13) rearrangement …